Business Description
![Diasorin SpA Diasorin SpA logo](https://static.gurufocus.com/logos/0C00000UP8.png?14)
Diasorin SpA
NAICS : 325413
ISIN : IT0003492391
Share Class Description:
MIL:DIA: Ordinary SharesCompare
Compare
Traded in other countries / regions
DIA.Italy0GZX.UKDIAS.AustriaDSRLF.USA34D.Germany IPO Date
2007-07-19Description
Diasorin SpA is a biotechnology company engaged in developing, producing, and marketing reagent kits for laboratory diagnostics around the world. The business has focused on the immunodiagnostic market, molecular diagnostics, and Life Science sector. The company has a presence in Italy, Europe, North America, and the Rest of the world, where the majority of its revenue is from North America followed by Italy.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.74 | |||||
Debt-to-EBITDA | 5.2 | |||||
Interest Coverage | 15.21 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.39 | |||||
Beneish M-Score | -2.79 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.8 | |||||
3-Year EBITDA Growth Rate | -1.9 | |||||
3-Year EPS without NRI Growth Rate | -11.7 | |||||
3-Year FCF Growth Rate | -5.2 | |||||
3-Year Book Growth Rate | 18.3 | |||||
Future 3-5Y EPS without NRI Growth Rate | 14.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 6.67 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 77.07 | |||||
9-Day RSI | 70.76 | |||||
14-Day RSI | 65.4 | |||||
6-1 Month Momentum % | 10.89 | |||||
12-1 Month Momentum % | -1.76 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.76 | |||||
Quick Ratio | 1.78 | |||||
Cash Ratio | 0.88 | |||||
Days Inventory | 278.82 | |||||
Days Sales Outstanding | 66.54 | |||||
Days Payable | 91.85 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.11 | |||||
Dividend Payout Ratio | 0.33 | |||||
3-Year Dividend Growth Rate | 5 | |||||
Forward Dividend Yield % | 1.11 | |||||
5-Year Yield-on-Cost % | 1.44 | |||||
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | 4.22 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 64.54 | |||||
Operating Margin % | 20.52 | |||||
Net Margin % | 14.28 | |||||
FCF Margin % | 30.06 | |||||
ROE % | 10.6 | |||||
ROA % | 5.54 | |||||
ROIC % | 7.13 | |||||
ROC (Joel Greenblatt) % | 67.76 | |||||
ROCE % | 8.38 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 33.58 | |||||
PE Ratio without NRI | 31.23 | |||||
Shiller PE Ratio | 28.03 | |||||
PEG Ratio | 2.87 | |||||
PS Ratio | 4.79 | |||||
PB Ratio | 3.4 | |||||
Price-to-Free-Cash-Flow | 15.95 | |||||
Price-to-Operating-Cash-Flow | 15.95 | |||||
EV-to-EBIT | 28.09 | |||||
EV-to-Forward-EBIT | 23.04 | |||||
EV-to-EBITDA | 28.09 | |||||
EV-to-Forward-EBITDA | 18.08 | |||||
EV-to-Revenue | 5.61 | |||||
EV-to-Forward-Revenue | 6.55 | |||||
EV-to-FCF | 18.51 | |||||
Price-to-Projected-FCF | 0.93 | |||||
Price-to-DCF (Earnings Based) | 1.53 | |||||
Price-to-DCF (FCF Based) | 0.76 | |||||
Price-to-Median-PS-Value | 0.79 | |||||
Price-to-Peter-Lynch-Fair-Value | 5.19 | |||||
Earnings Yield (Greenblatt) % | 3.56 | |||||
FCF Yield % | 6.24 | |||||
Forward Rate of Return (Yacktman) % | 12.08 |